1. Home
  2. LSCC vs LNTH Comparison

LSCC vs LNTH Comparison

Compare LSCC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSCC
  • LNTH
  • Stock Information
  • Founded
  • LSCC 1983
  • LNTH 1956
  • Country
  • LSCC United States
  • LNTH United States
  • Employees
  • LSCC N/A
  • LNTH N/A
  • Industry
  • LSCC Semiconductors
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • LSCC Technology
  • LNTH Health Care
  • Exchange
  • LSCC Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • LSCC 8.4B
  • LNTH 7.5B
  • IPO Year
  • LSCC 1989
  • LNTH 2015
  • Fundamental
  • Price
  • LSCC $54.90
  • LNTH $78.81
  • Analyst Decision
  • LSCC Strong Buy
  • LNTH Strong Buy
  • Analyst Count
  • LSCC 13
  • LNTH 5
  • Target Price
  • LSCC $65.46
  • LNTH $133.80
  • AVG Volume (30 Days)
  • LSCC 3.0M
  • LNTH 1.3M
  • Earning Date
  • LSCC 05-05-2025
  • LNTH 05-07-2025
  • Dividend Yield
  • LSCC N/A
  • LNTH N/A
  • EPS Growth
  • LSCC N/A
  • LNTH N/A
  • EPS
  • LSCC 0.37
  • LNTH 3.53
  • Revenue
  • LSCC $488,736,000.00
  • LNTH $1,536,699,000.00
  • Revenue This Year
  • LSCC $3.50
  • LNTH $5.81
  • Revenue Next Year
  • LSCC $18.74
  • LNTH $12.26
  • P/E Ratio
  • LSCC $151.05
  • LNTH $22.33
  • Revenue Growth
  • LSCC N/A
  • LNTH 12.53
  • 52 Week Low
  • LSCC $34.69
  • LNTH $74.34
  • 52 Week High
  • LSCC $78.29
  • LNTH $126.89
  • Technical
  • Relative Strength Index (RSI)
  • LSCC 60.32
  • LNTH 27.83
  • Support Level
  • LSCC $45.17
  • LNTH $78.61
  • Resistance Level
  • LSCC $57.23
  • LNTH $83.60
  • Average True Range (ATR)
  • LSCC 2.30
  • LNTH 3.82
  • MACD
  • LSCC 1.20
  • LNTH -2.99
  • Stochastic Oscillator
  • LSCC 80.68
  • LNTH 5.64

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: